Stryker releases 2021 second-quarter operating results, outlook
Stryker reported a net sales increase from both 2020 and 2019 this quarter, with a “positive outlook” on the rest of the year, according to a press release.
Within the second quarter, consolidated net sales increased by 55.4% from 2020 to $4.3 billion, and organic net sales increased by 42.9% from 2020. Consolidated net sales increased by 17.6% in the quarter from 2019; organic net sales increased by 9.3% from 2019.
For orthopedics, net sales were $1.6 billion, increasing by 82.3% in the quarter from 2020; organic net sales increased by 52.2% in the quarter from 2020. From 2019, orthopedics had a net sales increase of 27.8% in the quarter and organic net sales increase of 6.7% in the quarter.
The company also reported adjusted net earnings of $861 million from $245 million, making the adjusted earnings per share of $2.25, which increased from $0.64 in the quarter.
For the rest of the year, Stryker projects organic net sales increasing between 9% and 10% from 2019 and adjusted earnings per share between $9.25 and $9.40.
"We delivered strong financial results in the second quarter," Kevin Lobo, chair and CEO of Stryker, said in the release. "Business momentum continues to build as the pandemic moderates and the integration of Wright Medical is pacing ahead of plan.”
Read more about